Medigene AG (GB:0QGJ)
LSE:0QGJ
Holding GB:0QGJ?
Track your performance easily

Medigene (0QGJ) Financial Statements

1 Followers

Medigene Financial Overview

Medigene's market cap is currently ―. The company's EPS TTM is €-1.232; its P/E ratio is -1.22; Medigene is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is €-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Dec 19Sep 19
Income Statement-
Total Revenue£ 2.26M£ 2.15M£ 2.27M£ 3.59M£ 1.30M
Ebit£ -1.77M£ -2.35M£ -5.80M£ 115.00K£ -5.61M
Ebitda£ -1.77M£ -2.35M£ -5.80M£ 115.00K£ -5.61M
Net Income Common Stockholders£ -2.39M£ -2.44M£ -5.91M£ 29.00K£ -5.70M
Balance Sheet-
Total Assets£ 76.50M£ 66.88M£ 93.10M£ 109.22M£ 117.39M
Total Debt£ 3.48M£ 4.13M£ 4.92M£ 6.00M£ 6.38M
Net Debt£ -59.14M£ -49.46M£ -69.34M£ -81.82M£ -85.78M
Total Liabilities£ 17.36M£ 17.42M£ 23.76M£ 27.39M£ 31.61M
Stockholders Equity£ 59.14M£ 49.46M£ 69.34M£ 81.82M£ 85.78M
Cash Flow-
Free Cash Flow---£ -8.53M£ -2.98M
Operating Cash Flow---£ -7.10M£ -4.09M
Investing Cash Flow---£ 22.06M£ -43.00K
Financing Cash Flow---£ 1.21M£ -606.00K
Currency in GBP

Medigene Earnings and Revenue History

Medigene Debt to Assets

Medigene Cash Flow

Medigene Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis